You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3551 to 3575 of about 5998
Next 25
10/04/2008
Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)
Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.
A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).
Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.
Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM).
Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas.
Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.
A retrospective single institutional analysis of bevacizumab and chemotherapy versus non-bevacizumab treatments for recurrent glioblastoma.
Patterns of relapse and prognosis after bevacizumab (BEV) failure in recurrent glioblastoma (GBM).
NY Islanders Fundraiser for Brain Tumor Research
10/03/2008
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
TMZ-BioShuttle - a reformulated Temozolomide.
Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children`s Oncology Group.
Radiosurgery and carcinogenesis risk.
Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas.
Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.
09/30/2008
Maureen’s Autumn Days Calendar Raffle - to benefit brain cancer patients who need financial assistance
Radiosurgery for brain cancer OK for elderly
09/29/2008
Updated Ben Williams Survivor Story!
Dosing Initiated in TransMolecular’s Phase 1/2 Clinical Trial for Intravenous Administration of 131Iodine-TM601 in Patients with Recurrent Malignant Glioma
09/28/2008
Cell Phone Use and Tumors: What the Science Says
Temozolomide Not Superior to Procarbazine-Based Combination Treatment in Patients With High-Grade Glioma: Presented at ESMO
Avastin may increase risk of neural bleeding and stroke in patients with glioblastoma multiforme, physicians say
Median Brain Cancer Survival Doubles in Vaccine Trials